Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
The 2 Most Critical Elements of MSL Territory Excellence with Julie Montiel
Summary
In this episode, Tom Caravela is joined by Julie Montiel to explore the nuances of MSL territory excellence and the critical role of scientific acumen. They delve into strategies for achieving scientific acumen and crafting effective, individualized territory plans. The conversation highlights the significance of pre-call and post-call planning in managing territories, as well as adapting strategies for virtual and digital engagements. Julie shares tips to enhance virtual presentation skills, concluding with a recap on creating a plan for territory excellence. The episode wraps up with closing remarks on the importance of key MSL strategies and a call to action for listeners.
My guest today is Julie Montiel, the National Scientific Director, Lymphoma/Myeloid MSL at The Janssen. We talk about the two most critical of MSL territory excellence.
In this episode we discuss:
- Julie’s background
- The two most critical elements
- How MSLs improve their performance
- What is scientific acumen
- Why is scientific acumen the most important element of territory excellence
- What does excellence in scientific acumen look like?
- Every territory is different
- Applying principles to a virtual type of scenario
- How MSLs bring all of these pieces of information together to build strategic territory excellence
MSL territory excellence, scientific acumen, virtual presentation skills, strategic territory planning, MSL performance improvement
Related Topics
You May Also Like
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Podcast
MSL Talk: Tom Caravela, Josh Corriveau
MSL Career Options: The transition from Field Medical to Medical Director
Article
Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
Article
Sarah A. Weiss, MD, and Harriet Kluger, MD
CheckMate-067: Raising the Bar for the Next Decade in Oncology
Article
Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
Article
Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma